This resource provides information related to the SAPHNELO J-Code.
This letter contains a copy of the statement from the FDA approving SAPHNELO for use as recommended in the product labeling.

This letter contains a copy of the statement from the FDA approving WAINUA for use as recommended in the product labeling.

Ensure your patients complete and sign the WAINUA Patient Authorization Form so Access 360 can provide select services.
Patients can click here to complete the Patient Authorization Form online
Legally Authorized Representatives can click here to complete the Patient Authorization Form online
Legally Authorized Representative (LAR) is someone permitted by law to act on a patient’s behalf regarding healthcare decisions.
This resource will outline administration options, access support services and information on helping patients afford WAINUA.
This guide contains general information on support services, coding, reimbursement, and distribution for WAINUA.

This resource provides specific codes related to diagnosing and billing for WAINUA.

This resource provides details to support HCP offices through acquisition of buy-and-billing.

This sheet provides the contact information of authorized specialty pharmacy providers and specialty distributors through which WAINUA can be acquired.
This two-page resource describes how patients can get support for out-of-pocket costs for WAINUA if approved by insurance.
This resource explains affordability options for eligible patients who are prescribed WAINUA.

Checklists designed to be used as references during the prior authorization and denial/appeal processes for WAINUA.

This asset covers common payer requirements for prior authorization.

This template can be used by a healthcare provider to respond to a patient’s insurance company requesting a letter of medical necessity for prescribing an AstraZeneca specialty medicine.
Click here to download the Sample Letter of Medical Necessity Guide
Click here to download the Sample Letter of Medical Necessity
This template can be used by a healthcare provider to appeal a denial of access to an AstraZeneca medicine.
Click here to download the WAINUA Sample Letter of Appeal Guide
Click here to download the WAINUA Sample Letter of Appeal
Click here to download the WAINUA Compendium
This resource should be used as a guide to prepare for peer-to-peer reviews between a healthcare provider and payer after a denial of coverage for WAINUA.

This guide provides resources and information to ensure you have all the tools you need to help navigate the denial of an AstraZeneca medicine.
The AstraZeneca Access 360™ program provides personal support and resources to help streamline access and reimbursement for select AstraZeneca medicines, including WAINUA. These resources include the Benefits Investigations Report, the Denial Management Guide, and the Peer-to-Peer resource.